SUMMARY OBJECTIVE: The development of a biomarker of exposure based on the evaluation of the human antibody response specific to Anopheles salivary proteins seems promising in improving malaria control. The IgG response specific to the gSG6-P1 peptide has already been validated as a biomarker of An. gambiae exposure. This study represents a first attempt to validate the gSG6-P1 peptide as an epidemiological tool evaluating exposure to An. funestus bites, the second main malaria vector in sub-Saharan Africa. METHODS: A multi-disciplinary survey was performed in a Senegalese village where An. funestus represents the principal anopheline species. The IgG antibody level specific to gSG6-P1 was evaluated and compared in the same children before, at the peak and after the rainy season. RESULTS: Two-thirds of the children developed a specific IgG response to gSG6-P1 during the study period and--more interestingly--before the rainy season, when An. funestus was the only anopheline species reported. The specific IgG response increased during the An. funestus exposure season, and a positive association between the IgG level and the level of exposure to An. funestus bites was observed. CONCLUSIONS: The results suggest that the evaluation of the IgG response specific to gSG6-P1 in children could also represent a biomarker of exposure to An. funestus bites. The availability of such a biomarker evaluating the exposure to both main Plasmodium falciparum vectors in Africa could be particularly relevant as a direct criterion for the evaluation of the efficacy of vector control strategies.
SUMMARY OBJECTIVE: The development of a biomarker of exposure based on the evaluation of the human antibody response specific to Anopheles salivary proteins seems promising in improving malaria control. The IgG response specific to the gSG6-P1 peptide has already been validated as a biomarker of An. gambiae exposure. This study represents a first attempt to validate the gSG6-P1 peptide as an epidemiological tool evaluating exposure to An. funestus bites, the second main malaria vector in sub-Saharan Africa. METHODS: A multi-disciplinary survey was performed in a Senegalese village where An. funestus represents the principal anopheline species. The IgG antibody level specific to gSG6-P1 was evaluated and compared in the same children before, at the peak and after the rainy season. RESULTS: Two-thirds of the children developed a specific IgG response to gSG6-P1 during the study period and--more interestingly--before the rainy season, when An. funestus was the only anopheline species reported. The specific IgG response increased during the An. funestus exposure season, and a positive association between the IgG level and the level of exposure to An. funestus bites was observed. CONCLUSIONS: The results suggest that the evaluation of the IgG response specific to gSG6-P1 in children could also represent a biomarker of exposure to An. funestus bites. The availability of such a biomarker evaluating the exposure to both main Plasmodium falciparum vectors in Africa could be particularly relevant as a direct criterion for the evaluation of the efficacy of vector control strategies.
Authors: Dipomin F Traoré; André B Sagna; Akré M Adja; Dounin D Zoh; Kouassi N Lingué; Issa Coulibaly; Bertin N'Cho Tchiekoi; Serge B Assi; Anne Poinsignon; Mamadou Dagnogo; Franck Remoue Journal: Am J Trop Med Hyg Date: 2018-03-01 Impact factor: 2.345
Authors: Berlin Londono-Renteria; Jaymin C Patel; Meagan Vaughn; Sheana Funkhauser; Loganathan Ponnusamy; Crystal Grippin; Sam B Jameson; Charles Apperson; Christopher N Mores; Dawn M Wesson; Tonya M Colpitts; Steven R Meshnick Journal: Am J Trop Med Hyg Date: 2015-07-20 Impact factor: 2.345
Authors: Ellen A Kearney; Paul A Agius; Victor Chaumeau; Julia C Cutts; Julie A Simpson; Freya J I Fowkes Journal: Elife Date: 2021-12-23 Impact factor: 8.140
Authors: Laura Brosseau; Papa Makhtar Drame; Patrick Besnard; Jean-Claude Toto; Vincent Foumane; Jacques Le Mire; François Mouchet; Franck Remoue; Richard Allan; Filomeno Fortes; Pierre Carnevale; Sylvie Manguin Journal: PLoS One Date: 2012-09-24 Impact factor: 3.240
Authors: Kingsley Badu; Joram Siangla; John Larbi; Bernard W Lawson; Yaw Afrane; John Ong'echa; Franck Remoue; Guofa Zhou; Andrew K Githeko; Guiyun Yan Journal: Malar J Date: 2012-09-10 Impact factor: 2.979